A biopharmaceutical leader in the discovery and development of innovative medicines.

Regulus, a biopharmaceutical leader in the discovery and development of innovative medicines , aiming microRNAs, a set of miRNAs that affect the physiological regulatory mechanism of fibrosis was discovered, and has announced its new pre-clinical study results in Science Translational Medicine Journal that miR-21 contributed fibrogenesis and that there is a suitable candidate. As a target for antifibrotic therapies.

The study’s senior author Dana-Farber Edwin Alyea, co-authors are Kristen Stevenson, Haesook Kim, Michael Garcia, Vincent Ho, Philippe Armand, Corey Cutler, Jerome Ritz, Joseph Antin, and Robert Soiffer, all Dana-Farber.– Take agreement talk the notes along with the identification the chaperone or if a chaperone was offered, but rejected.

The MDU to advise its members of on chaperons includes: – Chaperone should for more intimate for intimate examinations like the genitals or thoracic The time well advisable to have an order to investigation under low light, where doctors need to. Is very close to to a patient done, for example, offer with an ophthalmoscope.